A detailed history of State Street Corp transactions in En V Veno Medical Corp stock. As of the latest transaction made, State Street Corp holds 24,600 shares of NVNO stock, worth $129,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,600
Previous 26,600 7.52%
Holding current value
$129,150
Previous $136,000 2.21%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$3.94 - $6.65 $7,880 - $13,300
-2,000 Reduced 7.52%
24,600 $133,000
Q3 2023

Nov 14, 2023

BUY
$3.16 - $5.74 $16,116 - $29,274
5,100 Added 23.72%
26,600 $143,000
Q1 2022

May 16, 2022

BUY
$4.42 - $7.0 $3,536 - $5,600
800 Added 3.86%
21,500 $137,000
Q4 2021

Feb 14, 2022

BUY
$6.23 - $10.24 $128,961 - $211,968
20,700 New
20,700 $136,000

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $49.7M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.